# Retrospective Analysis of the Effect of In-hospital Initiation of PCSK9i on Clinical Outcomes in Chinese ACS Patients

> **NCT06567418** · — · RECRUITING · sponsor: **Yun Dai Chen** · enrollment: 10000 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** alirocumab 75mg/2week
- **DRUG:** statin ± ezetimibe

## Key facts

- **NCT ID:** NCT06567418
- **Lead sponsor:** Yun Dai Chen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06567418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06567418, "Retrospective Analysis of the Effect of In-hospital Initiation of PCSK9i on Clinical Outcomes in Chinese ACS Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06567418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*